Personalized Multi-peptide Vaccination in CLL Patients

计划入组 20 人 · 首次发布于 2020 年 12 月 30 日

iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL

计划入组 56 人 · 首次发布于 2016 年 6 月 16 日

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

计划入组 593 人 · 首次发布于 2020 年 9 月 14 日

Fusion-VAC-XS15

immunotherapy (DrugAbuse)

Multipeptide Vaccine AML-VAC-XS15(University Of Tubingen)

IMAC Holdings

United States

TAC

Canada

ITC LIMITED

India

Personalized T-Cell Activator iTAC-XS15-CLL01 Demonstrates Safety and Immunogenicity in Phase 1 Chronic Lymphocytic Leukemia Trial

Ignite Proteomics' RPPA Assay Drives Complete Response in HER2-Negative Breast Cancer

Squires Erases PTAB Ax Of Dermatology IP Upheld At ITC